Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Shiting Li & Hongqin Wang. (2023) Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib. Drug Design, Development and Therapy 17, pages 3429-3437.
Read now
Read now
Xiaolin Hu, Mengmeng Dong, Xiao Liang, Ziling Liu & Quanshun Li. (2021) Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin. International Journal of Nanomedicine 16, pages 471-480.
Read now
Read now
Fahima Danesh Pouya, Yousef Rasmi, Irem Yalim Camci, Yusuf Tutar & Mohadeseh Nemati. (2021) Performance of capecitabine in novel combination therapies in colorectal cancer. Journal of Chemotherapy 33:6, pages 375-389.
Read now
Read now
Razieh Mohajerani, Farhad Shahi, Zahra Jafariazar & Minoo Afshar. (2021) Efficacy of topical Lawsonia inermis L. (Henna) hydrogel in fluorouracil-induced hand-foot syndrome: a pilot randomized double-blind placebo-controlled clinical trial. Cutaneous and Ocular Toxicology 40:3, pages 257-262.
Read now
Read now
Chengwu Tang, Wenming Feng, Ying Bao & Cheng Chen. (2020) Maintenance Chemotherapy with S-1 Following SOX Regimen Chemotherapy Improves Prognosis of Stage 3 Gastric Cancer After D2 Gastrectomy: A 5-Year Analysis. OncoTargets and Therapy 13, pages 12661-12666.
Read now
Read now
Laurence Ho, Mehrdad Bokharaei & Shyh-Dar Li. (2018) Current update of a thermosensitive liposomes composed of DPPC and Brij78. Journal of Drug Targeting 26:5-6, pages 407-419.
Read now
Read now
Articles from other publishers (53)
Małgorzata Zawrzykraj, Milena Deptuła, Karolina Kondej, Agata Tymińska & Michał Pikuła. (2023) The effect of chemotherapy and radiotherapy on stem cells and wound healing. Current perspectives and challenges for cell-based therapies. Biomedicine & Pharmacotherapy 168, pages 115781.
Crossref
Crossref
Maryam E. Mashaly, Hams M. Kotb, Amany A. Abdin & Sabiha E. Hedya. (2023) Thymidine phosphorylase as a molecular target for quercetin-incorporated collagen matrix in the prevention of hand–foot syndrome induced by capecitabine in rats. Canadian Journal of Physiology and Pharmacology 101:7, pages 340-348.
Crossref
Crossref
Mirjam de With, Leni van Doorn, Demi C. Maasland, Tessa A.M. Mulder, Esther Oomen-de Hoop, Bianca Mostert, Marjolein Y.V. Homs, Samira El Bouazzaoui, Ron H.J. Mathijssen, Ron H.N. van Schaik & Sander Bins. (2023) Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD. Biomedicine & Pharmacotherapy 159, pages 114232.
Crossref
Crossref
Eunjoo Kim, Sung-Soo Kim & Min-Ok Ryu. (2023) Palmar–plantar erythrodysesthesia syndrome resulting from toceranib phosphate in a dog with apocrine gland anal sac adenocarcinoma: a case report. Journal of Veterinary Science 24:6.
Crossref
Crossref
René Aloisio da Costa Vieira, Rhayssa Espósito Santos Campos, Marcos Antônio Amorim, Antônio Dircio Silveira, Luiz Carlos Navarro de Oliveira & Almir José Sarri. (2023) Sequels associated with breast cancer treatment: what is important to measure in a report. Mastology 33.
Crossref
Crossref
长丰 苗. (2023) Arnebiae Oil Combined with Epidermal Growth Factor for the Treatment of Sorafenib-Induced Hand-Foot Syndrome in 2 Cases. Advances in Clinical Medicine 13:03, pages 3336-3341.
Crossref
Crossref
Mathan Kumar Ramasubbu, Shampa Maji, Milan Padhan, Rituparna Maiti, Debasish Hota, Saroj Kumar Das Majumdar & Anand Srinivasan. (2022) Chemotherapy-induced hand foot syndrome: comparative efficacy and safety of pharmacological prophylaxis – systematic review and Bayesian network meta-analysis. BMJ Supportive & Palliative Care, pages spcare-2022-004011.
Crossref
Crossref
Yongfeng Chen, Liyuan Zhang, Cuiling Wei, Fangfang Chen & Jinbing Bai. (2021) Predictors of oral chemotherapy adherence at home among Chinese cancer patients: An observational prospective study. Journal of Clinical Nursing 31:23-24, pages 3428-3438.
Crossref
Crossref
Elif Demirci Saadet & Ibrahim Tek. (2022) Evaluation of chemotherapy‐induced cutaneous side effects in cancer patients. International Journal of Dermatology 61:12, pages 1519-1526.
Crossref
Crossref
Bonnie E. Gould Rothberg, Tammie E. Quest, Sai‐Ching J. Yeung, Lorraine C. Pelosof, David E. Gerber, Justin A. Seltzer, Jason J. Bischof, Charles R. ThomasJrJr, Nausheen Akhter, Mira Mamtani, Robin E. Stutman, Christopher W. Baugh, Venkataraman Anantharaman, Nicholas R. Pettit, Adam D. Klotz, Michael A. Gibbs & Demetrios N. Kyriacou. (2022) Oncologic emergencies and urgencies: A comprehensive review. CA: A Cancer Journal for Clinicians 72:6, pages 570-593.
Crossref
Crossref
Jessa Gilda P. Pandy, Paula Isabel G. Franco & Rubi K. Li. (2022) Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials. Supportive Care in Cancer 30:11, pages 8655-8666.
Crossref
Crossref
Pierre Martin, Damien Botsen, Mathias Brugel, Eric Bertin, Claire Carlier, Rachid Mahmoudi, Florian Slimano, Marine Perrier & Olivier Bouché. (2022) Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX). Nutrients 14:21, pages 4448.
Crossref
Crossref
Mouna Abdullah, Mohamed I. Mourad, Mahmoud Fathy & Azza El-Sissi. (2022) In Vitro Study of the Potential Role of Olive Oil Oleuropein in Modulating the 5-FU Cytotoxic Efficacy against the Tongue Squamous Cell Carcinoma. Open Access Macedonian Journal of Medical Sciences 10:A, pages 1347-1354.
Crossref
Crossref
Éder Gerardo dos Santos-Leite, Lorena Vieira Sacramento, Alessandra Monteiro Santana, Juliana Borges de Lima Dantas, Manoela Carrera & Gabriela Botelho Martins. (2022) Oral hyperpigmentation as an initial clinical aspect of hand foot syndrome. Brazilian Dental Journal 33:4, pages 97-102.
Crossref
Crossref
Brianna N. Richardson, Jolinta Lin, Zachary S. Buchwald & Jinbing Bai. (2022) Skin Microbiome and Treatment-Related Skin Toxicities in Patients With Cancer: A Mini-Review. Frontiers in Oncology 12.
Crossref
Crossref
Xueqiong Xun, Qinguang Cao, Pan Hong, Saroj Rai, Yeming Zhou, Ruikang Liu & Huiyong Hu. (2022) Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis. Frontiers in Oncology 12.
Crossref
Crossref
Sepideh Elyasi, Sara Rasta, Ali Taghizadeh-Kermani & Sare Hosseini. (2022) Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical. DARU Journal of Pharmaceutical Sciences 30:1, pages 117-125.
Crossref
Crossref
Xiaoying He, Jiali Wang, Qian Wang, Jing Liu, Xi Yang, Lingjuan He, Haihong Hu, Su Zeng, Lushan Yu, Yunqing Qiu & Yan Lou. (2022) P38 MAPK, NF-κB, and JAK-STAT3 Signaling Pathways Involved in Capecitabine-Induced Hand-Foot Syndrome via Interleukin 6 or Interleukin 8 Abnormal Expression. Chemical Research in Toxicology 35:3, pages 422-430.
Crossref
Crossref
Yu Yoshida, Sayaka Sasaoka, Mizuki Tanaka, Kiyoka Matsumoto, Misaki Inoue, Riko Satake, Kazuyo Shimada, Ririka Mukai, Takaaki Suzuki, Mari Iwata, Fumiya Goto, Takayuki Mori, Koki Mori, Tomoaki Yoshimura & Mitsuhiro Nakamura. (2022) Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database. Therapeutic Advances in Drug Safety 13, pages 204209862211019.
Crossref
Crossref
Analia Rodríguez-Garzotto, Lara Iglesias-Docampo, C. Vanesa Díaz-García, Isabel Ruppen, Pilar Ximénez-Embún, Carlos Gómez, J. Luis Rodríguez-Peralto, Javier Ortiz de Frutos, Jose A. Lopez-Martin, Cristina Grávalos, Hernán Cortés-Funes & M. Teresa Agulló-Ortuño. (2022) Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies. Therapeutic Advances in Medical Oncology 14, pages 175883592210869.
Crossref
Crossref
Victor Yazbeck, Erin Alesi, Jennifer Myers, Mary Helen Hackney, Laurie Cuttino & David A. Gewirtz. 2022. Strategies to Mitigate the Toxicity of Cancer Therapeutics. Strategies to Mitigate the Toxicity of Cancer Therapeutics
1
27
.
Zhen Yuan, Ying Zhang, Dongyan Cao, Keng Shen, Qingshui Li, Guonan Zhang, Xiaohua Wu, Manhua Cui, Ying Yue, Wenjun Cheng, Li Wang, Pengpeng Qu, Guangshi Tao, Jianqing Hou, Lixin Sun, Yuanguang Meng, Guiling Li, Changzhong Li, Huirong Shi & Yaqing Chen. (2021) Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer. Journal of Ovarian Research 14:1.
Crossref
Crossref
Mingming Li, Jiani Chen, Yi Deng, Tao Yan, Haixia Gu, Yanjun Zhou, Houshan Yao, Hua Wei & Wansheng Chen. (2021) Risk prediction models based on hematological/body parameters for chemotherapy-induced adverse effects in Chinese colorectal cancer patients. Supportive Care in Cancer 29:12, pages 7931-7947.
Crossref
Crossref
Ziyi Xu, Teng Li, Xingsheng Hu, Xuezhi Hao, Puyuan Xing & Junling Li. (2021)
Efficacy and safety profile of combining programmed cell death‐1 (
PD
‐1) inhibitors and antiangiogenic targeting agents as subsequent therapy for advanced or metastatic non‐small cell lung cancer (
NSCLC
)
. Thoracic Cancer 12:17, pages 2360-2368.
Crossref
Crossref
Eun-ji Kim, Chan-ran Park, Chang-gue Son, Jung-hyo Cho & Nam-hun Lee. (2021) The Effect of Traditional Korean Medicine for Chemotherapy-Induced Hand-Foot Syndrome in Cancer Patients: Review. The Journal of Internal Korean Medicine 42:3, pages 340-350.
Crossref
Crossref
Jiexiu Chen & Zhuo Wang. (2021) How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs. Journal of Oncology Pharmacy Practice 27:4, pages 919-929.
Crossref
Crossref
Mona M. Al Onazi, Janice L. Yurick, Claire Harris, Kacy Nishimura, Kirsten Suderman, Edith Pituskin, Neil Chua & Margaret L. McNeely. (2021) Therapeutic Ultrasound for Chemotherapy-Related Pain and Sensory Disturbance in the Hands and Feet in Patients With Colorectal Cancer: A Pilot Randomized Controlled Trial. Journal of Pain and Symptom Management 61:6, pages 1127-1138.
Crossref
Crossref
Shiori Hiromoto, Takehiro Kawashiri, Natsumi Yamanaka, Daisuke Kobayashi, Keisuke Mine, Mizuki Inoue, Mayako Uchida & Takao Shimazoe. (2021) Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome. Scientific Reports 11:1.
Crossref
Crossref
Michalis Stavrinou, Theologia Tsitsi, George Astras, Lefkios Paikousis & Andreas Charalambous. (2021) A randomised controlled feasibility trial to evaluate Lawsonia inermis (henna)'s effect on palmar-plantar erythrodysesthesia induced by capecitabine or pegylated liposomal doxorubicin. European Journal of Oncology Nursing 51, pages 101908.
Crossref
Crossref
Chenxu Ni, Juemin Fang, Hong Qian, Qing Xu & Fuming Shen. (2020) Liposomal doxorubicin-related palmar–plantar erythrodysesthesia (hand–foot syndrome): a case report. Journal of International Medical Research 48:12, pages 030006052097485.
Crossref
Crossref
Lamiaa R. Abdelalim, Yosra S. R. Elnaggar & Ossama Y. Abdallah. (2020) Oleosomes Encapsulating Sildenafil Citrate as Potential Topical Nanotherapy for Palmar Plantar Erythrodysesthesia with High Ex vivo Permeation and Deposition. AAPS PharmSciTech 21:8.
Crossref
Crossref
Kathleen Wiley, George Ebanks Jr.Gary Shelton, Jenna Strelo & Kathryn Ciccolini. (2020) Skin Toxicity: Clinical Summary of the ONS Guidelines™ for Cancer Treatment–Related Skin Toxicity. Clinical Journal of Oncology Nursing 24:5, pages 561-565.
Crossref
Crossref
Loretta Williams, Pamela Ginex, George Ebanks Jr.Karren Ganstwig, Kathryn Ciccolini, Bernice Kwong, Jeanene Robison, Gary Shelton, Jenna Strelo, Kathleen Wiley, Christine Maloney, Kerri Moriarty, Mark Vrabel & Rebecca Morgan. (2020) ONS Guidelines™ for Cancer Treatment–Related Skin Toxicity. Oncology Nursing Forum 47:5, pages 539-556.
Crossref
Crossref
Lukas Schlager, Katharina Wöran, Helena Luhn, Anton Stift & Felix Harpain. (2020) A Case Report of Capecitabine-Associated Bowel Inflammation With a Novel Mutation of the DPYD Gene. AJSP: Reviews and Reports 25:4, pages e8-e12.
Crossref
Crossref
Takeshi Okamoto, Koichi Takagi & Katsuyuki Fukuda. (2020) Oxaliplatin-Induced Lhermitte’s Sign in Gastric Cancer. Case Reports in Oncological Medicine 2020, pages 1-5.
Crossref
Crossref
Johannes J.M. Kwakman, Yannick S. Elshot, Cornelis J.A. Punt & Miriam Koopman. (2020) Management of cytotoxic chemotherapy-induced hand-foot syndrome. Oncology Reviews 14:1.
Crossref
Crossref
N. Reed, H. Glen, G. Gerrard, J. Good, M. Lei, A.R. Lyon, M. Strachan, J. Wadsley & K. Newbold. (2020) Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. Clinical Oncology 32:5, pages e145-e153.
Crossref
Crossref
Yue Ren, Ting Li, Lei‐Ya Du, Ye Qiu, Shan‐Bing Wang, Kai‐Jian Lei & Yu‐Ming Jia. (2020)
Apatinib‐induced
Grade
3 hand‐foot syndrome in advanced lung adenocarcinoma successful treated with thalidomide: A case report
. Dermatologic Therapy 33:2.
Crossref
Crossref
Gurleen Kaur Gill, Manik Chhabra & Sumit Pal Singh Chawla. (2020) Levofloxacin-induced Desquamation: A Possible and Rare Case Report. Current Drug Safety 15:1, pages 61-64.
Crossref
Crossref
Ya-Hui Hsu, Wen-Chi Shen, Chao-Hui Wang, Yu-Fen Lin & Shu-Ching Chen. (2019) Hand-foot syndrome and its impact on daily activities in breast cancer patients receiving docetaxel-based chemotherapy. European Journal of Oncology Nursing 43, pages 101670.
Crossref
Crossref
Vasiliki Nikolaou, D. Voudouri, G. Tsironis, A. Charpidou, G. Stamoulis, I. Triantafyllopoulou, I. Panoutsopoulou, E. Xidakis, A. Bamias, E. Samantas, G. Aravantinos, H. Gogas, D. Rigopoulos, K. Syrigos & A. Stratigos. (2019) Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients. Supportive Care in Cancer 27:12, pages 4535-4542.
Crossref
Crossref
Leslie Citrome. (2019) Reflections of a semi‐colon; Part 2, chemotherapy. International Journal of Clinical Practice 73:11.
Crossref
Crossref
Hiroko Komatsu, Kaori Yagasaki, Kenro Hirata & Yasuo Hamamoto. (2019) Unmet needs of cancer patients with chemotherapy-related hand-foot syndrome and targeted therapy-related hand-foot skin reaction: A qualitative study. European Journal of Oncology Nursing 38, pages 65-69.
Crossref
Crossref
Hedyieh Karbasforooshan, Sare Hosseini, Sepideh Elyasi, Azar Fani Pakdel & Gholamreza Karimi. (2019) Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial. Phytotherapy Research 33:2, pages 379-386.
Crossref
Crossref
Yihong Liu, Brian H. May, Anthony Lin Zhang, Xinfeng Guo, Chuanjian Lu, Charlie Changli Xue & Haibo Zhang. (2018) Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis. Integrative Cancer Therapies 18, pages 153473541881783.
Crossref
Crossref
Jennifer Wu, Alina Markova & Mario E. Lacouture. 2019. Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions. Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions
131
173
.
Yan Lou, Qian Wang, Jinqi Zheng, Xi Wang, Weiqin Jiang, Yi Zheng, Qingwei Zhao, Yunqing Qiu & Su Zeng. (2018) Identification of the Novel Capecitabine Metabolites in Capecitabine-Treated Patients with Hand-Foot Syndrome. Chemical Research in Toxicology 31:10, pages 1069-1079.
Crossref
Crossref
Shinya Suzuki, Shuichi Nawata, Yusuke Inada, Daisuke Sato, Junichi Kusano, Daisuke Ichikura, Kazuhiro Torigoe, Kazumi Ishitsuka, Fumiaki Sato, Hiroyasu Sakai & Tetsuro Yumoto. (2018) A cross-sectional survey of methods for controling hand-foot syndrome in patients receiving capecitabine treatment. Molecular and Clinical Oncology.
Crossref
Crossref
Francis H X Yap, Niamh O'Sullivan & Thomas A Delaney. (2018) Psoriasis aggravation due to capecitabine: A case study and review of the literature. Australasian Journal of Dermatology 59:3, pages e212-e213.
Crossref
Crossref
Simona Dostalova, Hana Polanska, Marketa Svobodova, Jan Balvan, Olga Krystofova, Yazan Haddad, Sona Krizkova, Michal Masarik, Tomas Eckschlager, Marie Stiborova, Zbynek Heger & Vojtech Adam. (2018) Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin. Scientific Reports 8:1.
Crossref
Crossref
Rashmi Advani & Danit Arad. (2018) Case Report: Non-infectious causes of palmoplantar rashes, what to consider. F1000Research 7, pages 46.
Crossref
Crossref
Azael Freites-Martinez & Mario E. Lacouture. 2018. The MASCC Textbook of Cancer Supportive Care and Survivorship. The MASCC Textbook of Cancer Supportive Care and Survivorship
597
620
.
Sepideh Elyasi, Farzaneh Sadat Rezazadeh Shojaee, Abolghasem Allahyari & Gholamreza Karimi. (2017) Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytotherapy Research 31:9, pages 1323-1329.
Crossref
Crossref